Si descrivono le attività e le responsabilità dello statistico professionale nella conduzione di una prova clinica in una industria farmaceutica o in un ente di ricerca.
@article{BUMI_2003_8_6A_1_119_0, author = {Mauro Gasparini}, title = {La statistica nelle prove cliniche}, journal = {Bollettino dell'Unione Matematica Italiana}, volume = {6-A}, year = {2003}, pages = {119-140}, zbl = {1194.62113}, mrnumber = {1982350}, language = {it}, url = {http://dml.mathdoc.fr/item/BUMI_2003_8_6A_1_119_0} }
Gasparini, Mauro. La statistica nelle prove cliniche. Bollettino dell'Unione Matematica Italiana, Tome 6-A (2003) pp. 119-140. http://gdmltest.u-ga.fr/item/BUMI_2003_8_6A_1_119_0/
- , Pharmacokinetics, Dekker, 1982.
Toward evidence-based medical statistics. 1: The P-value fallacy, Annals of Internal Medicine, 130(1999a), 995-1004.
,Toward evidence-based medical statistics. 2: The Bayes factor, Annals of Internal Medicine, 130(1999b), 1004-1013.
,International Conferenceon Harmonization, Statistical principles for clinical trials, http://www.ifpma.org/ich5e.html (1998).
- (Eds.), Group Sequential Methods with Applications to Clinical Trials, CRC Press, 1999. - , Applied Statistics in the Pharmaceutical Industry, Springer, 2001. , Clinical Trials. A methodological perspective, Wiley, 1997.Statistica methods for population pharmacokinetic modelling, Statistica Methods in Medical Research, 7 (1998), 63-84.
- , , Statistical Issued in Drug Development, Wiley, 1997.Bayesian approaches to randomized trials, Journal of the Royal Statistical Society series A, 157(1994), 357-416. | MR 1321308 | Zbl 1001.62529
- - ,